Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is TALENT Biotechs' primary focus in drug development?
- TALENT Biotechs specializes in developing cannabidiol-based therapies, particularly for the prevention and treatment of graft-versus-host disease.
- When was TALENT Biotechs founded?
- TALENT Biotechs was founded in January 2014.
- What is the current status of TALENT Biotechs?
- TALENT Biotechs is currently inactive, having been acquired by Kalytera Therapeutics in February 2017.
- Who acquired TALENT Biotechs and when?
- TALENT Biotechs was acquired by Kalytera Therapeutics, based in Beverly, Massachusetts, United States, in February 2017.
- What was the acquisition amount for TALENT Biotechs?
- TALENT Biotechs was acquired for $10,000,000 in February 2017.
- What is TALENT Biotechs' employee count?
- TALENT Biotechs had between 1-10 employees, with an exact count of 6.
- Where is TALENT Biotechs headquartered?
- TALENT Biotechs is headquartered in Bnei Brak, Center District, Israel.
- What is an example of a technology success story for TALENT Biotechs?
- In February 2017, TALENT Biotechs had a technology success story related to Cannabidiol-based drugs for the treatment of GvHD, categorized under Pharmaceuticals & Diagnostics.
- Who is a known founder of TALENT Biotechs?
- Moshe Yeshurun is identified as a founder of TALENT Biotechs.